{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:45:36Z","timestamp":1794012336024,"version":"4.8.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Groningen and the University of Groningen; Indonesia Endowment Fund for Education","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Real-world evidence on a potential statin effect modification by sex is inconclusive, especially for the primary prevention of cardiovascular disease (CVD). We aimed to quantify the differences in the effect of statins on lipid parameters between men and women.<\/jats:p>\n            <jats:p>The PharmLines Initiative linked the Lifelines Cohort Study and the IADB.nl prescription database. This database covers a representative population from the Netherlands. We selected participants aged \u226540\u200ayears at the index date: the date of the first prescription of any statin monotherapy in the study period 2006 to 2017. Multivariate regression modeling was used to compare the difference of the mean percentage change of lipid parameters (% mean difference [MD]) from baseline to follow-up measurement between the sexes.<\/jats:p>\n            <jats:p>Out of 5366 statin users from approximately 50,000 participants available in the final linked database, 685 were statin initiators. At baseline, women had significantly higher levels of mean total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) than men (all <jats:italic toggle=\"yes\">P<\/jats:italic> values &lt;.01). At follow-up, women had a significantly higher mean percentage change of HDL-C compared to men (adjusted % MD 5.59, 95% confidence interval [CI] 2.42-8.75, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01). There was no significant sex difference in other parameters, nor in the proportion of men and women who achieved LDL-C \u22642.5\u200ammol\/L.<\/jats:p>\n            <jats:p>Statins appear to have a greater effect on increasing HDL-C levels in women than men while showing similar effect on other lipid parameters in both sexes. Men should not be treated differently than women.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028394","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T13:07:41Z","timestamp":1642165661000},"page":"e28394","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Sex disparities in the effect of statins on lipid parameters"],"prefix":"10.1097","volume":"101","author":[{"given":"Nicholas B.","family":"Hunt","sequence":"first","affiliation":[{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"},{"name":"Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E.","family":"Emmens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6278-9017","authenticated-orcid":false,"given":"Sylvi","family":"Irawati","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"},{"name":"Centre for Medicines Information and Pharmaceutical Care, Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia"},{"name":"Department of Clinical and Community Pharmacy, Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"de Vos","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens H.J.","family":"Bos","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"},{"name":"University of Groningen, Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"R5-20250504","first-page":"e1046","article-title":"2018\u200aAHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016\u200aESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2011.09.067","article-title":"Meta-analysis of statin effects in women versus men","volume":"59","author":"Kostis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.phrs.2016.12.027","article-title":"Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: the never-ending debate","volume":"117","author":"Cangemi","year":"2017","journal-title":"Pharmacol Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2017.08.014","article-title":"Effects of age, gender and statin dose on lipid levels: results from the VOYAGER meta-analysis database","volume":"265","author":"Karlson","year":"2017","journal-title":"Atherosclerosis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database","volume":"340","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/heartjnl-2016-310216","article-title":"Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare","volume":"103","author":"Hyun","year":"2017","journal-title":"Heart"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","article-title":"Gender and racial disparities in adherence to statin therapy: a meta-analysis","volume":"165","author":"Lewey","year":"2013","journal-title":"Am Heart J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e0155228","DOI":"10.1371\/journal.pone.0155228","article-title":"Drivers of the sex disparity in statin therapy in patients with coronary artery disease: a cohort study","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1503\/cmaj.060627","article-title":"Sex differences in the effectiveness of statins after myocardial infarction","volume":"176","author":"Karp","year":"2007","journal-title":"CMAJ"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijcard.2016.11.061","article-title":"The LifeLines Cohort Study: prevalence and treatment of cardiovascular disease and risk factors","volume":"228","author":"van der Ende","year":"2017","journal-title":"Int J Cardiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erp.13.20","article-title":"The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges","volume":"13","author":"Visser","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort profile: LifeLines, a three-generation cohort study and biobank","volume":"44","author":"Scholtens","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/CLEP.S163037","article-title":"Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort Study with the pharmacy database IADB.nl: the PharmLines Initiative","volume":"10","author":"Sediq","year":"2018","journal-title":"Clin Epidemiol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-007-9204-4","article-title":"Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study","volume":"23","author":"Stolk","year":"2008","journal-title":"Eur J Epidemiol"},{"key":"R23-20250504","first-page":"A5104","article-title":"Samenvatting van de multidisciplinaire richtlijn \u2018Cardiovasculair risicomanagement\u2019 (herziening 2011) [Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)]","volume":"156","author":"Wiersma","year":"2012","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacl.2010.08.026","article-title":"The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review","volume":"4","author":"Simpson","year":"2010","journal-title":"J Clin Lipidol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1194\/jlr.P002816","article-title":"Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER database","volume":"51","author":"Barter","year":"2010","journal-title":"J Lipid Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/clc.4960261106","article-title":"Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups","volume":"26","author":"Davidson","year":"2003","journal-title":"Clin Cardiol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1900\/RDS.2013.10.213","article-title":"Paradoxical negative HDL cholesterol response to atorvastatin and simvastatin treatment in Chinese type 2 diabetic patients","volume":"10","author":"Chang","year":"2013","journal-title":"Rev Diabet Stud"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5551\/jat.5405","article-title":"Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions","volume":"17","author":"Yamashita","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/03007995.2017.1281109","article-title":"A systematic review to assess adherence and persistence with statins","volume":"33","author":"Deshpande","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.clinthera.2017.03.001","article-title":"Use of lipid-modifying therapy and LDL-C goal attainment in a high-cardiovascular-risk population in the Netherlands","volume":"39","author":"Kuiper","year":"2017","journal-title":"Clin Ther"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e0137203","DOI":"10.1371\/journal.pone.0137203","article-title":"Representativeness of the Lifelines Cohort Study","volume":"10","author":"Klijs","year":"2015","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:24:32Z","timestamp":1746332672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028394"}},"subtitle":["The PharmLines Initiative"],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028394","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"2020-11-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}